Greg Rustowicz
Analyst · Dougherty & Company. Please proceed
Thank you, Rick. Good morning, everyone. On Slide 6, net sales in the third quarter were a $199.4 million. As you know, we completed three divestitures last fiscal year, which reduced sales this quarter by $9 million compared to last year. Foreign currency also contribute – continued as a headwind and reduced our sales by $1.7 million.Adjusted for FX in the divestitures, we saw sales volume declined by $10.6 million or 5.2%. While volume was down, our pricing power was evident as we saw pricing improved by 1.6%, which was the same amount as last quarter. But half of this pricing was a result of our 80/20 strategic pricing initiatives.Let me provide a little color regarding sales by region. For the third quarter, we saw sales volume decline in the US by 4.2%. This was partially offset by price increases of 1.7%. Sales outside of the US were down 6.5% adjusting for the FX of divestitures.Solid price improvement of 1.4% partially offset a volume decline of 6.2%. Sales volume was down in EMEA, Latin America and Canada, but up in the APAC region as result of a large rail project. The weakness we saw in EMEA was in both our short cycle and project businesses.Let’s now review orders and backlog. Our short cycle business continued to be affected by the contraction of industrial markets. This headwind impacted our project business during the December quarter as well.Adjusted for divestitures, orders were down year-over-year by 9.5% overall. It is important to note, that quoting activity remains high in both the number of quotes and dollar value, but our senses is that projects are being somewhat delayed, especially in the US. As a result, backlog was reduced to $125 million at the end of December.While the markets are certainly a headwind, we believe that our strong market position and leading brands will dampen the effect of the industrial market slowdown. We continue to focus on customer responsiveness and ramping the growth engine. As Rick discussed, we have formed an automation division which will introduce new products that will expand addressable market and grow share in key markets.On Slide 7, our gross margin was 34% in the quarter. This is a 20 basis point expansion in gross margin from a year ago, and our 11th consecutive quarter of year-over-year margin expansion on a GAAP basis. As Rick mentioned earlier, we benefited from the 80/20 Process, which drove $5.7 million of gross profit expansion through strategic pricing, indirect overhead reductions and certain volume gains at our targeted accounts. This benefit was more than offset by the impact of the divestitures, lower sales volume and mix and higher medical cost and lower fixed cost absorption or factories due to inventory reductions which are included in the productivity, net of other cost changes category on the bridge.Let’s now review the quarters’ gross profit bridge. Third quarter gross profit of $67.9 million was down $3.5 million compared to the prior year adjusted for the divestitures. We did see gross profit expansion from pricing, net of material cost inflation and tariffs were lower than the prior year as we imported less Chinese products. We incurred $500,000 of one-time costs for the factory closures in Ohio and China. Foreign currency translation also reduced gross profit by $600,000. Productivity, net of other cost changes was negative $2.2 million. This was the result of $1.1 million of higher medical costs and the impact of reducing the inventories by $7 million, which negatively – affected fixed cost absorption in our factories.As shown on Slide 8, RSG&A was $43.8 million in the quarter or 21.9% of sales. RSG&A was $3.8 million lower than the previous year period. The reduction in RSG&A was due to several factors; the impact of the divestitures reduced RSG&A by $1 million and the benefit of FX of approximately $400,000. In addition, our G&A costs benefited from a $2 million reduction in stock compensation expense from the departure of our previous CEO.While we are controlling RSG&A costs as macroeconomic conditions create headwinds, we are also actively investing for growth and key initiatives. We continue to invest in product development, marketing and digital projects, while reducing costs in other parts of the organization. Taking this into account, we are forecasting our third quarter RSG&A to be in a range of $45 million to $45.5 million.Turning to Slide 9, adjusted operating income grew 1.1%. When you normalize for the divestitures, adjusted operating income grew 5.7% to $23.1 million. Adjusted operating margin was 11.6% of sales, a 110 basis point improvement over the prior year. With our blueprint for growth strategy, and specifically our 80/20 Process, we were able to grow adjusted operating income, despite an overall decline in revenue of 8.3%, which is outstanding operating leverage.As you can see on Slide 10, GAAP earnings per diluted share for the quarter was $0.63. Adjusted earnings per diluted share was $0.64 compared with $0.61 in the previous year, an increase of $0.03 per share or about 5%.On a GAAP basis, our tax rate for the quarter was 12.8%, as we partially reverse the deferred tax asset valuation allowance in the amount of $1.9 million. This valuation allowance was originally recorded in fiscal 2019 relating to certain foreign tax credits generated by the one-time transition tax, as a result of the Tax Cuts and Jobs Act. We reversed the valuation allowance and the foreign tax credits utilized in our fiscal 2019 federal income tax return. With this benefit, we are now expecting this year’s full year tax rate to be approximately 21% to 22%.On Slide 11, we continue to expand our adjusted EBITDA margin. For the quarter, our adjusted EBITDA margin was 15.2%, an increase of 100 basis points over last year. We’re also making progress and driving our ROIC higher and are now at 11.9%, an increase of 140 basis points from last year’s third quarter. This progress demonstrates that we are tracking our blueprint for growth strategic goals to achieve a 19% adjusted EBITDA margin in fiscal ‘22 and achieve an adjusted ROIC in the mid-teens.Moving to Slide 12, one of the hallmarks of Columbus McKinnon is its ability to generate cash throughout this business cycle. Net cash from operating activities for the quarter was $32 million, which was a year-over-year increase of $6 million or 24%. Year-to-date, we have generated $63.5 million of free cash flow. This represents about 94% of the free cash flow we generated last fiscal year and we still have one quarter to go. Consequently, we are raising our free cash flow guidance to $75 million to $80 million for this fiscal year.Turning to Slide 13, our total debt at the end of the quarter was approximately $252 million and our net debt was $168 million. Our net debt to net total capitalization is now approximately 26%. We repaid $20 million of debt in the third quarter and reduced our term loan debt by nearly $185 million since acquiring STAHL in January of 2017. We made excellent progress de-levering and have achieved a net debt to adjusted EBITDA level – leverage ratio of 1.3 times, while providing us the financial flexibility to advance into phase three of our strategy. We expect our leverage ratio to be 1.1 times to 1.2 times by fiscal year end.Let me reiterate on Page 14, our thoughts on capital allocation. We will continue to use our financial flexibility to invest in growth initiatives. We also invest in CapEx projects to provide good cost savings, as these will be accretive to our overall financial objectives. While we have achieved our net leverage target, we will continue to use our surplus cash to pay down debt and de-lever the balance sheet for the remainder of this fiscal year.We plan to deploy capital for smart M&A as we move into phase three of our blueprint for growth strategy. We also plan to pay a dividend that is consistent and grows over time. Our final priority will be share repurchases that we would consider opportunistically as we weigh our other capital allocation priorities.Please turn to Slide 15, and I will turn it back over to Rick.